50% off the $29.99 Custom Kit. Use at checkout:
⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
AEO Score: 6/10
Monitoring for AI engine activity
In the Engagemii AEO index
#22,587 of 454,542 in Healthcare for AI visibility
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. evrysdi just got measured.
6/10 means evrysdi is somewhat visible. AI bots can read you, but you are missing the structured signals that would push citation rate above competitors.
Evrysdi® (risdiplam) is a Spinal Muscular Atrophy (SMA) treatment that can be administered at home and is approved for use in adults, children, and infants. Please see Important Safety information, including the Full Prescribing Information for more details.
Industry: Healthcare
evrissdi.com5
Structured Data
7
Content Structure
7
Entity Clarity
4
E-E-A-T Signals
6
Technical AEO
4
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for evrysdi.
Scored by Engagemii on July 11, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/evrissdi
Cite this score: Engagemii (2026). "AEO Score for evrysdi." Retrieved from https://engagemii.com/aeo/brands/evrissdi
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform